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Abstract
Background: This study examines changes in physical functioning among adults aged 50-79 years in Germany
based on data from two German National Health Interview and Examination Surveys conducted in 1997–1999
(GNHIES98) and 2008–2011 (DEGS1).
Methods: Using cross-sectional data from the two surveys (GNHIES98, n = 2884 and DEGS1, n = 3732), we examined
changes in self-reported physical functioning scores (Short Form-36 physical functioning subscale (SF-36 PF)) by sex
and age groups (50–64 and 65–79 years). Covariables included educational level, living alone, nine chronic diseases,
polypharmacy (≥5 prescribed medicines), body mass index, sports activity, smoking and alcohol consumption.
Multimorbidity was defined as ≥2 chronic diseases. Multivariable models were fitted to examine consistency of
changes in physical functioning among certain subgroups and to assess changes in mean SF-36 PF scores,
adjusting for changes in covariables between surveys.
Results: Mean physical functioning increased among adults aged 50–79 years between surveys in unadjusted
analyses, but this change was not as marked among men aged 65–79 years who experienced rising obesity
(20.6 to 31.5%, p = 0.004) and diabetes (13.0 to 20.0%, p = 0.014). Prevalence of multimorbidity and polypharmacy use
increased among men and women aged 65–79 years. In sex and age specific multivariable analyses, changes in physical
functioning over time were consistent across subgroups. Gains in physical functioning were explained by improved
education, lower body mass index and improved health-related behaviours (smoking, alcohol consumption, sports
activity) in women, but less so among men.
Conclusions: Physical functioning improved in Germany among adults aged 50–79 years. Improvements in the
population 65–79 years were less evident among men than women, despite increases in multimorbidity prevalence
among both sexes. Changes in health behaviours over time differed between sexes and help explain variations in
physical functioning. Targeted health behaviour interventions are indicated from this study.
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Background
As the worldwide phenomenon of unprecedented
human longevity becomes progressively realised, how we
understand, measure and improve health in later life is
increasingly shaping our approaches to population mon-
itoring and public health. Globally, investigators are
shifting analytical strategies beyond crude measures of
mortality and single diseases. Efforts now concentrate on
measures interlinked with healthcare costs, such as
healthy life expectancy that focus on the number of
years a person at a given age can expect to live in good
health given their age-specific mortality, morbidity and
functional health status [1, 2]. Findings from the Global
Burden of Disease study indicate that in many countries
increases in life expectancy over the last two decades
have occurred alongside a rise in the number of years
spent in disability [2], an expansion of morbidity [3].
These findings emphasise the relatively minor progress
made in reducing the overall effects of chronic diseases
on population health compared with recent successes in
increasing survival [4].
Multimorbidity, the coexistence of two or more
chronic conditions [5] is now the standard for many
older people in developed countries [5, 6]. Major conse-
quences of multimorbidity include functional decline,
disability, poor quality of life and high healthcare costs
[7]. Changing patterns of activity limitations have been
the focus of several national [8, 9] and international
studies [10, 11] using large population datasets including
older adults. Findings have been mixed, with activity
limitations reported as generally stable over time in the
Netherlands [9], particularly among those with severe
disability [12] but reducing in several northern European
countries [10, 13, 14]. In the US, there is evidence that
mobility disability has increased over time, particularly
among certain groups, such as those with obesity [15].
Recent evidence from the US has revealed widening gaps
between sexes and over the last 30 years men’s active life
expectancy at age 65 years has increased by 4.5 years (to
more than 15 years), but only by 1.4 years for women
(to more than 14 years) [16].
Germany is currently the second oldest population in
the world with 27.6% of the population aged 60 years or
over, surpassed only by Japan (33.1%) [17]. Chronic
ischaemic heart disease (IHD) is by far the leading cause
of mortality in the country, followed by stroke; and IHD
is one of the most common causes of lost healthy years,
particularly among men [18]. Multimorbidity is com-
mon, particularly for those aged 50 years and over with
prevalence markedly increasing with age [19]. Little is
known about temporal changes in physical functioning
at a population level in Germany and investments to de-
velop public health interventions and optimise health
care for older people include enhanced comprehensive
population health monitoring and epidemiological
studies which enable surveillance over time [20, 21].
Against this background, this study investigates
changes in physical functioning over time in two
national health surveys of adults in Germany conducted
in 1997–1999 and 2008–2011. We investigate whether
changes in physical functioning were consistent within
age and sex strata of the population aged 50–64 and
65–79 years. We further examine if any changes can
be explained by changes in health determinants, including
sociodemographic and behavioural risk factors, and
changes in the prevalence of chronic disease.
Methods
Study design and study population
Our study draws on cross-sectional data from two
national German health surveys carried out by the Robert
Koch Institute as part of a continuous health monitoring
programme about a decade apart [20]. The German
National Health Interview and Examination Survey 1998
(GNHIES98) was conducted from October 1997 to March
1999 and the German Health Interview and Examination
Survey for Adults (DEGS1) from November 2008 to
December 2011. These surveys are based on nationally
representative samples of the resident population in
Germany aged 18–79 years. People unable to provide
written consent and those with significant language bar-
riers were excluded from participation [20].
The design and sampling procedures of the surveys
have been previously reported in detail [20, 22, 23]. Both
surveys used two-stage random sampling procedures.
Primary sample units (PSUs) are the communities.
These were randomly sampled from a complete list of
German communities proportional to community size.
Within PSUs, random samples of the population 18–79
years were drawn from local population registries.
GNHIES98 was based on 120 PSUs and included a total
of 7124 persons 18–79 years of age and had a response
rate of 61%. In DEGS1, the number of PSUs was ex-
tended to 180 as surviving GNHIES98 participants were
invited to participate in DEGS1 in order to establish a
survey panel component. Random sampling in DEGS1
at the individual level was conducted to maintain a
nationally representative sample at the population level
[20]. Overall 7115 persons 18–79 years of age partici-
pated in DEGS1 and completed both the interview and
examination survey parts. Response rates in DEGS1
were considerably higher among persons who also par-
ticipated in GNHIES98 (response rate: 64%) compared
to those newly sampled for DEGS1 (response rate: 42%).
Both surveys included self-administered question-
naires, standardised physician-administered computer-
assisted personal interview (CAPI), physiological
measurements and tests [20, 24] and robust data
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collection on the use of medicines in the seven days
prior to examination [25]. In the present analysis, we
included participants aged 50–79 years with complete
interview and examination data and information on
physical functioning (Fig. 1).
Participants provided written informed consent prior
to interview and examination in both studies. Both
studies were conducted according to the Federal and
State Commissioners for Data Protection guidelines.
DEGS1 was approved by the Charité-Universitätsmedizin
Berlin ethics committee (No. EA2/047/08).
Physical functioning
Validated self-administered German language versions
[26] of the Medical Outcome Short Form-36 (SF-36) [27]
were used in both surveys [28]. The self-reported 10-item
physical functioning subscale (SF-36 PF) was the focus of
this analysis. The SF-36 PF subscale is a valid marker of
mobility disability in epidemiological studies of older
people [29], and may be less susceptible to changes in
living environments and technology over time than other
measures of activities of daily living disability [30]. SF-36
PF scores range from 0 to 100 points with higher values
indicating better physical functioning [31].
Covariables
A number of covariables with known associations with
physical functioning were investigated in this study.
Socio-demographic variables included age, sex and
household size (living alone or with others). Education
level was classified as low, medium and high using the
Comparative Analysis of Social Mobility in Industrial
Nations (CASMIN) scale [32].
Body mass index (BMI) was calculated using the
standard formula (weight (kg)/[height (m)]2), and cate-
gorised into <25 kg/m2, 25–29.9 kg/m2 and >30 kg/m2
[33]. Smoking status was classified as current, former or
never smoking. Alcohol consumption was classified as
risky drinking (consuming ≥10 g of alcohol per day for
women and ≥20 g per day for men); moderate consump-
tion (<10 g per day for women and <20 g per day for
men) and no alcohol consumption (0 g per day) [34].
Responses about the frequency and duration of engage-
ment in any sports activities in the previous three
months [35] enabled individuals to be classified as
performing ≥2 h per week; less than 2 hours per week;
and no sports.
Self-reported physician-diagnosed prevalence of chronic
diseases was measured in both surveys (‘Has a doctor ever
told you that you have …?’). Nine diseases, with compar-
able data were available including: ischemic heart disease
(IHD) (including myocardial infarction and angina
pectoris), chronic heart failure, stroke, hypertension, hyper-
lipidaemia, cancer (history of any type), asthma, osteopor-
osis and diabetes, which additionally included participants
taking diabetes medicines [36]. We classified respondents
by their number of self-reported chronic conditions (0, 1, 2,
3 or more) and as having multimorbidity (2 or more
chronic diseases) [5]. Data on medication use was sum-
marised in a single measure of polypharmacy defined as the
use of 5 and more prescription medicines in the 7 days
prior to survey examination [25].
Statistical analyses
IBM SPSS software (version 20.0, SPSS Inc. Chicago, IL)
was used for analyses. It was necessary to take into
Fig. 1 Flow diagram of study sample
Buttery et al. BMC Geriatrics  (2016) 16:205 Page 3 of 11
account demographic changes in the German population
between surveys. The age structure of the population
changed from 1998 and numerous chronic conditions
are age-related. Therefore, age-standardized sampling
weights were computed for the GNHIES98 sample to
the population structure as of 31 December 2010, enab-
ling comparisons with the DEGS1 sample [36, 37].
Participants’ characteristics are summarised by survey
(GNHIES98 and DEGS1). Given the potential for he-
terogeneity of population subgroups, we investigated
sex-specific age groups 50–64 and 65–79 years, consistent
with others using similar approaches [12, 16]. Prevalence
estimates for each chronic condition were calculated
excluding those with missing data.
A total of 509 or 7.7% of study participants had missing
observations in some variables with a range of 0.2% for
smoking, 0.5% for educational status, 0.8% for body mass
index, to 5.0% for the number of chronic conditions. The
variable ‘number of chronic conditions’ had the most
missing values (n = 330) among all covariables ranging
from 67 among men aged 50–64 years to 103 among
women aged 65–79 years (Table 1). The numbers of
persons with missing values are explicitly stated for each
variable (Table 1). Persons with missing values were
excluded from the analyses, with pairwise deletion for de-
scriptive and listwise deletion for multivariable analyses.
Differences between participant’s characteristics in
GNHIES98 and DEGS1 were examined using second-
order Rao-Scott chi-square tests for categorical variables.
We used the SPSS Complex Samples General Linear
Model (CSGLM) procedure to measure the change in
the mean physical functioning between the surveys with
adjustment of covariables in multivariable models. To
enable international comparability and comparisons
between SF-36 versions 1 and 2 used in the surveys we
calculated “norm-based scoring” whereby the SF-36
scales were first z-transformed using the average values
and standard deviations of the 1998 American normative
random sample [28]. Full details on subscale items, scor-
ing procedures and handling partially missing data are
provided (Additional file 1).
In order to investigate whether changes in physical
functioning were consistent within age and sex strata of
the population 50–64 and 65–79 years of age we fitted
multiple age and sex specific models. We further exam-
ine if any change can be explained by changes in health
determinants including sociodemographic and behav-
ioural risk factors and changes in the prevalence of
chronic disease. Multivariable models were restricted to
participants with valid data on all model covariables.
Unadjusted and fully adjusted models are presented and
sensitivity analyses substituting variables that are likely
to be closely associated i.e. replacing polypharmacy for
multimorbidity were conducted. Interaction tests were
performed to examine interactions between surveys and
key covariables (educational level, BMI categories, multi-
morbidity) within age and sex stratified analyses.
Results
Table 1 summarises the characteristics of the German
National Health Interview and Examination Survey par-
ticipants in 1997–1999 and 2008–2011, stratified by age
groups and sex.
The proportion of older women (65–79 years) living
alone decreased between the surveys whilst men (50–64
years) living alone increased. Educational levels and self-
reported sports activity levels were higher in the more
recent survey for all age and sex groups. The proportions
of men aged 65–79 years with obesity rose between the
survey periods. There were changes in smoking status and
differing patterns occurred for men and women with
improved smoking habits among older men, but the pro-
portion of women aged 50–64 years smoking increased.
Moderate drinking increased significantly in all subgroups
except for men aged 65–79 years, but improvements in
risky drinking occurred only in men aged 50–64 years.
Prevalence estimates between surveys changed for
some chronic diseases: IHD declined among women;
hypertension rose for men and women in both age
groups; diabetes rose among older men; asthma rose
among older women but declined among older men.
Multimorbidity and polypharmacy use significantly rose
among men and women aged 65–79 years.
Figure 2 shows physical functioning (unadjusted mean
SF-36PF scores) which increased significantly between
the surveys for all groups except men aged 65–79 years.
In cross-sectional analyses, men had consistently higher
mean physical functioning than women. Improvements
in physical functioning occurred despite increasing
multimorbidity.
We examined SF-36PF scores and their associations
with all covariables across age groups and sex (see online
Additional file 2: Table S1 for full details). Some consist-
ent patterns for both sexes were found, including linear
relationships between better physical functioning and
more sports activity per week; and poorer physical func-
tioning among those with more chronic diseases and
higher use of polypharmacy. Smoking was associated
with lower SF-36PF scores only among men. There was
no evidence of interactions between survey period and
educational level, BMI category or multimorbidity status
(Additional file 2: Table S1).
Table 2 summarises the unadjusted and fully adjusted
multivariable linear regression models assessing the
absolute change in mean SF-36PF score between the
surveys, by sex and age groups.
Full models with all covariables are available online
(Additional file 3: Table S2). For men and women rising
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Table 1 Characteristics of German National Health Interview and Examination Survey participants 1997–1999 (GNHIES 98) and 2008–2011(DEGS1) included in this analysis by sex
and age groups
Men Women










n = 945 n = 929 n = 429 n = 856 n = 975 n = 1076 n = 535 n = 871
%/mean %/mean %/mean %/mean %/mean %/mean %/mean %/mean
Age, years (mean ± SE) 56.4 ± .14 56.4 ± .15 .936 70.9 ± .17 71.0 ± .16 .655 56.6 ± .14 56.4 ± .15 .417 71.5 ± .17 71.3 ± .16 .374
Household size
Living alone 6.6 13.5 <.001 12.5 9.6 .180 14.6 15.7 .531 41.6 32.2 .004
Living with others 93.4 86.5 87.5 90.4 85.4 84.3 58.4 67.8
Educational level(CASMIN)
Low 60.4 44.9 <.001 70.2 58.1 .005 63.4 40.9 <.001 82.1 69.2 <.001
Medium 22.1 37.9 15.5 23.1 28.0 48.0 14.6 24.2
High 17.5 17.2 14.3 18.9 8.5 11.1 3.3 6.6
Body mass index (BMI)kg/m2
(mean ± SE)
28.2 ± .15 28.2 ± .18 .773 27.8 ± .19 28.5 ± .19 .011 28.1 ± .22 27.4 ± .24 .275 28.6 ± .27 28.8 ± .21 .622
BMI <25a 18.0 20.4 .339 21.2 17.1 .004 31.4 36.3 .092 23.4 24.8 .336
BMI≥ 25 to <30 54.3 50.6 58.2 51.5 39.5 35.0 42.4 38.1
BMI≥ 30 27.7 28.9 20.6 31.5 29.2 28.7 34.2 37.2
Smoking status
Current 28.7 28.0 .003 17.6 10.1 <.001 17.8 24.9 <.001 10.5 8.2 <.001
Former 37.7 45.4 58.2 51.9 15.2 33.0 10.9 20.0
Never 33.6 26.6 24.2 37.9 67.1 42.1 78.6 71.7
Sports activity level
No sports (0 h/ week) 52.8 38.1 <.001 68.8 43.2 <.001 54.0 32.1 <.001 75.5 39.3 <.001
Regular sport (<2 h/week) 30.4 38.0 16.5 33.8 30.8 43.2 17.9 42.3
Regular sport (≥2 h/week) 16.8 24.0 14.7 23.0 15.1 24.8 6.6 18.4
Alcohol consumption
No alcohol (0 g/day) 12.3 7.3 <.001 11.0 7.1 .125 26.4 16.8 <.001 39.4 21.3 <.001
Moderate drinking
(<20/10 g/day, men/women)
56.8 72.7 64.9 67.9 58.8 66.4 52.8 68.8
Risky drinking
(≥20/10 g/day, men/women)












Table 1 Characteristics of German National Health Interview and Examination Survey participants 1997–1999 (GNHIES 98) and 2008–2011(DEGS1) included in this analysis by sex
and age groups (Continued)
Chronic diseases
Ischaemic heart disease 10.3 9.3 .590 29.4 27.9 .648 5.7 3.2 .022 19.7 14.2 .031
Chronic heart failure 3.9 3.2 .515 14.3 13.5 .755 3.1 2.7 .663 16.3 11.6 .084
Stroke 1.7 2.5 .357 7.3 7.6 .882 .7 .5 .534 6.1 5.6 .714
Hypertension 33.9 47.6 <.001 48.2 68.0 <.001 33.6 41.4 .001 55.5 68.7 <.001
Dyslipidaemia 39.4 41.4 .499 33.9 51.7 <.001 34.9 37.4 .379 43.1 57.5 <.001
Diabetes mellitus 10.8 9.7 .514 13.0 20.0 .014 5.6 5.6 .991 16.2 18.5 .375
Cancer (any type) 3.4 4.4 .334 9.9 15.4 .015 7.5 10.4 .049 7.3 14.3 <.001
Asthma 4.8 5.1 .796 7.1 4.4 .046 6.3 7.3 .428 3.8 8.8 .004
Osteoporosis 2.5 2.5 .998 1.9 3.4 .209 10.3 5.7 .003 20.6 22.7 .457
Number of chronic diseases
0 37.1 31.6 .197 20.3 11.4 <.001 35.1 31.1 .282 16.4 9.8 .018
1 31.6 32.7 33.2 25.3 34.1 38.4 25.2 23.1
2 18.4 22.1 20.9 29.9 21.8 21.0 27.4 29.8
≥3 12.9 13.6 25.6 33.4 9.0 9.6 30.9 37.3
Multimorbidity
≥ 2 chronic diseases 31.3 35.7 .105 46.6 63.3 <.001 30.8 30.5 .897 58.3 67.1 .010
Polypharmacy
≥5 prescribed medications 8.2 10.7 .158 26.3 34.1 .010 12.4 12.6 .900 30.2 37.0 .038
All percentages and means were weighted and standardized to the population of 31.12.2010
p values refer to differences between GNHIES98 and DEGS1 (Second-order Rao-Scott chi-square tests for categorical variables and general linear models for continuous variables)
aIncludes 20 persons with BMI <18.5 kg/m2
Missing values: Household size (men 50–64 years n = 7, men 65–79 years n = 3; women 50–64 years n = 9, women 65–79 years n = 13), Educational status (9, 6; 7, 8), Body mass index (7, 8; 11, 26), Smoking
status (2, 1; 3, 6), Physical activity level (11, 10; 12, 10), Alcohol consumption (23, 14; 16, 20), Ischaemic Heart Disease (11, 19; 22, 28), Chronic heart failure (21, 38; 29, 41), Stroke (6, 9; 10, 8), Hypertension (13, 7; 12, 5), Hyperlipidaemia












physical functioning was partially explained by rising
educational levels between survey periods (Additional file
3: Table S2). Multimorbidity appeared to contribute to
changes in physical functioning particularly among older
men and women (Additional file 3: Table S2 models 7 and
9). The influence of health behaviours and obesity in
models had different effects for men and women
(Additional file 3: Table S2, models 3–6). Behavioural
health risks explained rising physical functioning
among women at all ages, particularly improved
sports activity levels, and despite increased smoking
prevalence (Additional file 3: Table S2). There was no
evidence of interactions between survey period and
strata of education, BMI or multimorbidity status
among men and younger women. There was some
evidence of interaction between survey period and
BMI for older women (see Additional file 2: Table S1
for full details). Sensitivity analyses involved substitut-
ing polypharmacy for multimorbidity and results were
similar (Additional file 3: Table S2).
Discussion
Physical functioning (SF-36PF subscale scores) improved
in the German population aged 50–79 years between
1997–99 and 2008–11, but changes over time differed
by sex and age groups (50–64 and 65–79 years).
Increases in mean SF-36PF over time were of similar
magnitude among men and women aged 50–64 years
and among older women, but were less notable among
older men in unadjusted models. Rising obesity and dia-
betes among older men found in this study may help ex-
plain this finding. Improvements in physical functioning
among persons 65–79 years occurred despite increases
in multimorbidity prevalence and polypharmacy use over
the same period. Multivariable analyses indicated that
gains in physical functioning were explained by im-
proved education, lower BMI and improved health-
related behaviours (smoking, alcohol consumption,
sports activity) in women, but less so among men.
Increasing physical functioning
Valid comparisons with other large-scale studies examin-
ing changes in physical functioning over time is challen-
ging due to the range of activity limitations instruments
available, variations in the age of study participants and
different analytical techniques. Our findings are consistent
with a Dutch study of older non-institutionalised population
aged 55–84 years, conducted from 1990 to 2008, reporting
slight decreases in the prevalence of activity limitations for
SF-36 items over time, despite rising chronic diseases preva-
lence [38]. One potential explanation for these findings is
that diseases have become less disabling and have less
impact on physical functioning [38]. In a recent study in the
US, investigating activity limitations across five national
datasets, the percentage of the population 65–84 years with
one or more activity limitation was found to be stable since
2000 and declines in the 1980s and 1990s have paused [39].
However, for those less than 65 years our finding of
improved physical functioning over time differs from
observations in the US [39] and in France [40]. In these pre-
vious studies, an expansion of certain disability dimensions
for those in mid-life (aged 50–65 years), has raised concerns
about rising prevalence of functioning problems and disabil-
ity for this age group but different measurement instru-
ments may explain why our findings are more consistent
with the Dutch study [38].
Table 2 Multivariable analysis of the absolute change in the mean SF-36 physical functioning subscale score among participants in
the German National Health Interview and Examination Survey 1997–1999 (GNHIES 98) and 2008–2011 (DEGS1) included in
this analysis by sex and age groups
Men Women
Change in mean 95% CI p R2 Change in mean 95% CI p R2
50–64 years DEGS1 vs. GNHIES 98 (Unadjusted) 1.78 0.86 2.71 <.001 .011 1.61 0.71 2.52 .001 .008
DEGS1 vs. GNHIES 98 (Adjusteda) 1.63 0.79 2.46 <.001 .142 0.36 −0.61 1.33 .466 .155
65–79 years DEGS1 vs. GNHIES 98 (Unadjusted) 1.11 −0.21 2.44 .098 .003 1.66 0.33 2.99 .014 .006
DEGS1 vs. GNHIES 98 (Adjusteda) 0.68 −0.79 2.15 .360 .131 0.43 −1.05 1.92 .567 .137
Weighted and standardized to the population of 31.12.2010
Change in mean: Derived from SPSS Complex Samples General Linear Model (CSGLM) with physical functioning as the dependent variable
aadjusted for living alone (yes vs. no), education (low, medium, high), BMI (<25, 25–30, ≥30 mg/m2), smoking status (current, former and never), regular sports
activity (0, <2, ≥2 h/week), alcohol consumption (no, moderate and risky drinking), multimorbidity (yes, no)
Figures in bold denote statistical significance (p < .050)
Fig. 2 Mean SF-36 physical functioning scores among participants in the
German National Health Interview and Examination Survey 1997–1999
(GNHIES 98) and 2008–2011 (DEGS1) included in this analysis by
sex and age groups
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Sex differences
We observed better physical functioning among men
than women in cross-sectional analyses, consistent with
a previous cross-sectional study of adults aged 55–89
years in Denmark and Russia using the SF-36 PF sub-
scale [41]. Men have been reported to have lower preva-
lence of functional limitations and disability consistently
across many countries including continental Europe, the
UK and the US [10, 42]. The male–female health sur-
vival paradox [43], which describes how men live shorter
but healthier lives than women, may help explain this
finding which has occurred in the context of rising life
expectancy more so for men than for women in
Germany over this period [44].
We found significant rises in polypharmacy use
among older men and women, consistent with popu-
lation studies in Sweden [45] and the US [46]. Earlier
diagnoses of conditions that influence cardiovascular
health such as hypertension, hyperlipidaemia and
diabetes and improved access and use of cardiopro-
tective medicines [25] may explain rising polyphar-
macy. Declining use of menopausal hormone therapy,
a phenomenon also described in US populations over
this period [47], may have influenced polypharmacy
results among women.
Explanatory variables
Unsurprisingly, lower education, increasing BMI, lower
levels of sports activity, and a more adverse health status
(increasing number of chronic health conditions and
polypharmacy) were consistently associated with lower
physical functioning in all age and sex groups and in
both surveys. In accordance with previous results [15],
changes in physical functioning over time were less
favourable among persons with obesity compared to
non-obese persons in the present study, albeit results of
interaction tests were not significant. There was no evi-
dence for a differential change in physical functioning
over time according to educational level or multimorbid-
ity status. Modifiable lifestyle risk factors have been as-
sociated with poorer physical functioning (SF-36) among
adults aged 59 to 73 in England, with the more risk fac-
tors present, the worse the physical functioning [48].
However, in our study the contributions of these vari-
ables to explain changes in physical functioning were in-
consistent across age and sex strata. Education improved
over time in all subgroups, and helped to explain im-
proved physical functioning particularly among older
women in multivariable models. Among younger
women, behavioural factors including improved BMI
and sports activity levels appeared to play a larger role
in explaining changes in physical functioning. Smoking
has specifically been associated with poorer physical per-
formance among women [49] and our concerning
finding of rising smoking prevalence among women
aged 50–64 years suggests that smoking cessation strat-
egies need to target these women who lag behind men
in the tobacco epidemic [50].
Strengths and limitations
Strengths of our study include using nationally representa-
tive data and standardised valid data collection tools to
assess changes in physical functioning, chronic health con-
ditions, and various health determinants. However, people
with severe disease and impairments, including cognitive
impairment, are likely to be under-represented due to the
survey age range (18–79 years) and the need to travel to
survey sites for examinations. Therefore, functional limita-
tion prevalence estimates may be underestimated.
Our study was limited by comparable data availability
on chronic diseases in both surveys. Important conditions
such as chronic obstructive pulmonary disease (COPD),
musculoskeletal disorders and mental illness that may
impact on physical functioning are missing from this ana-
lysis. Although, older people self-report certain diseases
(such as cardiovascular events and diabetes) fairly accur-
ately [51], conditions such as heart failure may be less
reliably reported [52] and under and over reporting may
have occurred. We defined diseases in terms of their
presence but did not measure disease severity.
Implications
Retaining a high level of functioning, in addition to living
until old age without major morbidity and disability, is a
central concept of healthy ageing [53]. Monitoring popula-
tion health and understanding different dimensions of
physical functioning and disabilities and their relationships
with chronic disease is increasingly important for societies
with ageing populations and rising multimorbidity. Estab-
lished multifactorial inventions that improve physical
functioning and maintain independence for older people
[54] require increased implementation and our results
suggest further attention is needed on developing and
delivering effective interventions targeting health risk factors
such as smoking, BMI, and diabetes while considering sex
and birth cohort specific changes in health risks profiles.
Measuring functional status objectively with performance
tests may contribute to our understanding of the relation-
ships between diseases, objective functioning, and self-rated
disability [38]. Refined comprehensive comparable health
indicators including both physical and cognitive functioning
are essential to fully understand and improve health trends
among ageing societies and to investigate compression or
expansion of morbidity and disability [3, 55, 56].
Conclusion
This nationally representative study demonstrates that
physical functioning improved over the first decade of
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the 21st century among adults 50–79 years in Germany.
Improvements in the population 65–79 years were less
evident among men than women, despite increases in
multimorbidity prevalence and polypharmacy use among
both sexes. These changes occurred alongside improve-
ments in some, but not all, modifiable health determi-
nants with considerable differences across age group and
sex groups. Higher education, lower BMI, and healthier
behaviours, in particular higher sports activity were con-
sistently associated with better physical functioning.
Changes in physical functioning were no less favourable
among subgroups with multimorbidity or lower
education, and those with obesity. Changes in health
risk behaviours and their contribution to change in phys-
ical functioning varied by age and sex. Targeted health
behaviour interventions are indicated from this study,
along with continued and comprehensive surveillance of
morbidity and functioning.
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